Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Labetalol Oral Tablet
NIFEdipine ER
Locations
1
United States
Nebraska Methodist Women's Hospital
Omaha, Nebraska, United States
Start Date
June 20, 2022
Primary Completion Date
May 1, 2024
Completion Date
December 1, 2024
Last Updated
April 12, 2024
NCT06773299
NCT06576544
NCT07298759
NCT04626245
NCT05852054
NCT07185204
Lead Sponsor
Nebraska Methodist Health System
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions